Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study Eugenio de Miguel; Cristina Fernández-Carballido; Jordi Gratacós; José L. Pablos; Xavier Juanola; Rafael Ariza; Pau Terradas-Montana; Cristina Sanabra; Carlos Sastré;

Changes in immature granulocyte levels and their association with disease activation following biologic therapy in patients with ankylosing spondylitis Burak Okyar; Servet Yüce; ¿brahim Halil Bilen; Bekir Torun; ¿lyas Öztürk; Gözde Y¿ld¿r¿m Çetin;

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;